Free Trial

Aquestive Therapeutics (AQST) SEC Filings & 10K Form

Aquestive Therapeutics logo
$5.80 +0.03 (+0.52%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$5.77 -0.03 (-0.52%)
As of 10/3/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Aquestive Therapeutics SEC Filings

DateFilerForm TypeView
10/01/2025
7:41 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2025
3:26 PM
Aquestive Therapeutics (Issuer)
Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2025
3:26 PM
Aquestive Therapeutics (Issuer)
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Barber Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2025
3:05 PM
Aquestive Therapeutics (Subject)
Boyd Peter E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/26/2025
3:32 PM
Aquestive Therapeutics (Subject)
Barber Daniel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/22/2025
4:25 PM
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2025
3:45 PM
Aquestive Therapeutics (Subject)
Barber Daniel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/08/2025
6:06 PM
Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2025
4:13 PM
Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2025
7:32 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2025
9:32 AM
Aquestive Therapeutics (Subject)
Boyd Peter E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2025
3:26 PM
Aquestive Therapeutics (Subject)
Jung Cassie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2025
6:11 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2025
7:41 AM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2025
8:37 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025
4:29 PM
Aquestive Therapeutics (Filer)
Form 424B5
08/14/2025
5:26 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2025
6:54 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
6:48 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2025
12:57 PM
Aquestive Therapeutics (Issuer)
Taglietti Marco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
12:58 PM
Aquestive Therapeutics (Issuer)
Cochran John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
12:59 PM
Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
12:59 PM
Aquestive Therapeutics (Issuer)
MORRIS TIMOTHY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
12:59 PM
Aquestive Therapeutics (Issuer)
Krop Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
1:13 PM
Aquestive Therapeutics (Issuer)
BROWN GREGORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:21 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
1:12 PM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2025
8:10 AM
Aquestive Therapeutics (Issuer)
Cioffi Melina (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/25/2025
3:31 PM
Aquestive Therapeutics (Filer)
Form DEF 14A
04/25/2025
3:33 PM
Aquestive Therapeutics (Filer)
Form DEFA14A
04/25/2025
3:34 PM
Aquestive Therapeutics (Filer)
Form ARS
04/01/2025
7:26 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
4:47 PM
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:47 PM
Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:47 PM
Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:48 PM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:48 PM
Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:48 PM
Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:48 PM
Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:49 PM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:10 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
3:29 PM
Aquestive Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
5:12 PM
Aquestive Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/13/2025
10:38 AM
Aquestive Therapeutics (Subject)
BRATTON DOUGLAS K (Filed by)
Form SCHEDULE 13G/A
02/12/2025
6:22 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:51 PM
Aquestive Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/13/2025
6:07 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
7:02 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
7:08 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:40 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:42 PM
Aquestive Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
7:05 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
7:06 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
Aquestive Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/16/2024
4:16 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AQST) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners